Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Oncology

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.28.5.1201PMID 16596236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.

  2005cited by this paper
• IL‐2 induces expression and secretion of IFN‐γ in murine peritoneal macrophages

  2005cited by this paper
• IL-2 induces expression and secretion of IFN-gamma in murine peritoneal macrophages.

  2005cited by this paper
• Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.

  2004cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.

  2002cited by this paper
• Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide1

  2001cited by this paper
• Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1

  2000cited by this paper
• Alternative versus Classical Activation of Macrophages

  2000cited by this paper
• Antigen presentation by MHC class I and its regulation by interferon gamma.

  1999cited by this paper
• Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.

  1999cited by this paper
• Role of interleukin-2 receptor expression on macrophages from Salmonella-infected mice.

  1999cited by this paper
• Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

  1999cited by this paper
• IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.

  1999cited by this paper
• Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors.

  1998cited by this paper
• The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

  1996cited by this paper
• Mouse NK1.1+ T cells: a new family of T cells.

  1996cited by this paper
• Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

  1994cited by this paper
• Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages

  1994cited by this paper
• The immunobiological effects of interleukin-2 in vivo

  1994cited by this paper
• Murine natural killer cells and marrow graft rejection.

  1992cited by this paper
• Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.

  1992cited by this paper
• Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy

  1992cited by this paper
• Augmentation of recombinant interleukin‐2‐dependent murine macrophage‐mediated tumour cytotoxicity by recombinant tumour necrosis factor‐α

  1989cited by this paper
• Interferon‐gamma treatment of B16 melanoma cells: Opposing effects for non‐adaptive and adaptive immune defense and its reflection by metastatic spread

  1988cited by this paper
• Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes

  1986cited by this paper
• Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.

  1986cited by this paper
• Structure and expression of a cloned cDNA for human interleukin-2

  1983cited by this paper
• Selective in vitro growth of T lymphocytes from normal human bone marrows.

  1976cited by this paper

• Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines

  2025cites this paper
• Model Systems for the Study of Malignant Melanoma.

  2021cites this paper
• Anti-tumor and Chemoprotective Effect of Bauhinia tomentosa by Regulating Growth Factors and Inflammatory Mediators.

  2016cites this paper
• Immunotherapy of MHC class I-deficient tumors.

  2010cites this paper
• In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

  2009cites this paper
• Cancer Immunotherapy and Aging: Lessons From the Mouse

  2009cites this paper
• In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by γδ T and NK cells during the early steps of tumor growth

  2009cites this paper
• The importance of the age factor in cancer vaccination at older age

  2009cites this paper
• Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.

  2009cites this paper
• Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer

  2009cites this paper
• Cancer vaccination: manipulation of immune responses at old age.

  2009cites this paper
• Skewing the Th cell phenotype toward Th1 alters the maturation of tumor‐infiltrating mononuclear phagocytes

  2008cites this paper
• TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma.

  2007cites this paper